MOVES-Pershing Square's Valeant analyst to exit, Ackman optimistic price
August 26, 2016 at 17:48 PM EDT
BOSTON, Aug 26 (Reuters) - Billionaire investor William Ackman said on Friday that Jordan Rubin, who had worked closely on the controversial investment in battered drug maker Valeant Pharmaceuticals, is leaving the hedge fund.
